Aquestive Therapeutics Inc (AQST) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $4.63 (-0.64%), Market cap $0.52B, 52-week low–high $2.27 ~ $7.49.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in pat
Financial statements, price targets, institutional (13F) holdings and related news for Aquestive Therapeutics Inc are updated in real time on BlackAll Trade.
Aquestive Therapeutics Inc trades at $4.63 (-0.64%). Real-time quotes and charts are available on BlackAll Trade.
Aquestive Therapeutics Inc has a market cap of about $0.52B.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seiz